Close
Help
Need Help?



Forthcoming Articles 25 - 29 June 2012

Posted Thu, Jun, 28,2012

Libertas is pleased to announce that during the week of 25 - 29 June 2012 production commenced for the following articles:

Analytical Chemistry Insights

Simultaneous Determination of Sitagliptin and Metformin in Pharmaceutical Preparations by Capillary Zone Electrophoresis and its Application to Human Plasma Analysis

Clinical Medicine Insights: Case Reports

Typical spike-and-wave activity in hypoxic-ischemic brain injury and its implications for classifying nonconvulsive status epilepticus

Clinical Medicine Insights: Oncology

Review of immunotherapy for advanced prostate cancer

Clinical Medicine Insights: Therapeutics

Management options in chronic obstructive pulmonary disease

Ophthalmology and Eye Diseases

Gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis: safety, efficacy and patient perspective

Substance Abuse: Research and Treatment

When research meets reality – Lessons learned from a pragmatic multi-site group-randomized clinical trial on psychosocial interventions in the psychiatric and addiction field

To receive notifications of new articles immediately upon publication sign up for email alerts

share on

Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Libertas Academica
I enjoyed doing the recent peer review and after reading the article felt that I was witnessing a new way of thinking and examining issues.  Thank you for allowing me to be a part of this exciting venture into discovery.
Professor Joe Beck (Eastern Kentucky University, Richmond, USA)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results